This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES: Oligonucleotide & Peptide Therapeutics Content Hub
24/7 Access
Digital & In-Person
Menu

Jo-Anne Riley
Senior Scientist, Oligonucleotide Services at Intertek Pharmaceutical Services
Speaker

Profile

Jo-Anne began her analytical chemistry career in 2007 with an undergraduate placement in the Structural and Separation Science team at Pfizer. This was followed by a Chemistry PhD at the University of Southampton focussed on mass spectrometry of oligonucleotides.
Jo-Anne has five years’ experience working to cGMP standards performing analytical method development and validation and routine analysis for batch release and stability studies using a range of analytical techniques. This academic background in therapeutic oligonucleotides combined with industrial experience of GMP analysis led to Jo-Anne joining Intertek’s Oligonucleotide Services team in April 2018.

Agenda Sessions

  • CASE STUDY: CMC Considerations for mRNA Based Therapeutics - Analytical Approaches to Characterize Capital Quality Attributes

    On Demand - For Members